Table: Phoenixbio -2018/19 group results

PhoenixBio

15/05/2019 07:30

May 15 (Reuters)- 
          Phoenixbio Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended      Year ended       Year to        NEXT     
               Mar 31, 2019    Mar 31, 2018   Mar 31, 2020      YEAR       
                  LATEST         YEAR-AGO        COMPANY        COMPANY    
                 RESULTS          RESULTS       FORECAST      H1 FORECAST  
  Sales            1.23           902 mln         1.69          743 mln    
               (+36.1 pct)      (-26.6 pct)    (+37.4 pct)    (+74.2 pct)  
  Operating    loss 311 mln    loss 268 mln      117 mln      loss 46 mln  
  Recurring    loss 279 mln    loss 267 mln      137 mln      loss 42 mln  
  Net
  Net          loss 297 mln    loss 270 mln      122 mln      loss 43 mln  
  EPS        loss 101.96 yen  loss 93.36 yen    41.94 yen   loss 14.86 yen 
  Ann Div          NIL              NIL            NIL                     
  -Q2 Div          NIL              NIL            NIL                     
  -Q4 Div          NIL              NIL            NIL                     
  
  NOTE - Phoenixbio Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T